Abstract
Maculopathy is the commonest cause of severe visual loss from diabetic retinopathy in Jamaica [5]. Ophthalmic assessment of 158 black Jamaican maturity onset diabetics referred randomly from the primary and secondary health centres, demonstrated maculopathy in 48% of patients. Duration of diabetes was a strong risk factor for maculopathy (p<0.001). Poor compliance with diabetic and hypertensive therapy may influence the prevalence of maculopathy.
Similar content being viewed by others
References
Blakenship G. Diabetic macular edema and argon laser photocoagulation: a prospective randomized study. Ophthalmol 1979; 86: 69–78.
Bresnick G. Diabetic maculopathy. A critical review high-lighting diffuse macular edema. Ophthalmol 1983; 90: 1301–17.
Early treatment diabetic retinopathy study research group report No 1. Photocoagulation for diabetic macular edema. Arch Ophthalmol 1985; 103: 1796–1806.
Klein R, Klein B, Moss S, Davies M, De Mets D. The wisconsin epidemiological study of diabetic retinopathy IV. Diabetic macular edema. Ophthalmol 1984; 91: 1464–73.
Moriarty BJ, Acheson RW, Char JN, Serjeant GR. Diabetic retinopathy and visual loss in a Jamaican population. West Ind. Med. J. 1987; 36: 14–16.
Morrison EY, Richards R. Clinical profile of diabetes mellitus in Jamaica (phasic insulin dependence). West Ind. Med. J. 1985; 34: 94–97.
Olk RJ. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmol. 1986; 93: 938–48.
Patz A, Schatz H, Berkow J, Gittelsohn A, Ticho U. Macular edema: An overlooked complication of diabetic retinopathy. Trans. Am. Acad. Ophthalmol. Otolaryngol. 1973; 77: 34–42.
Townsend C, Bailey J, Kohner E. Xenon Arc photocoagulation for the treatment of diabetic maculopathy: Interim report of a multicentre controlled clinical study. Br. J. Ophthalmol. 1980; 64: 385–91.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moriarty, B.J., Dunn, D.T. & Moriarty, A.P. Diabetic maculopathy in a Jamaican population. Int Ophthalmol 13, 301–303 (1989). https://doi.org/10.1007/BF02279865
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02279865